Authorisation of Non-Innovator Biotherapeutic (Biosimilar) Products in the USA

European competent authorities began to elaborate scientific principles of development of non-innovator biotherapeutic (biosimilar) products in the early noughties, and in 2009 these principles were approved at the WHO International Conference in Seoul gathering participants from countries with a we...

Full description

Bibliographic Details
Main Authors: A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev, V. D. Mosyagin
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2019-03-01
Series:Биопрепараты: Профилактика, диагностика, лечение
Subjects:
Online Access:https://www.biopreparations.ru/jour/article/view/185